Wire · opportunities
'Pan-RAS molecular glue' is a safe and effective treatment for lung and pancreatic cancers
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 21 November 2026 · Fusion42 review
The Phase I AURORAS-1 trial shows ERAS-0015, a pan-RAS molecular glue, is safe and effective in shrinking tumors in patients with RAS-mutant lung and pancreatic cancers, offering a promising treatment for previously hard-to-treat cases.
This Wire brief sits within Fusion42's coverage of Biotech.
◆ ◆ The Wire takeaway
Your biotech startup now faces a shift where targeting RAS mutations with molecular glues is viable, opening a path to develop drugs for cancers long viewed as untreatable. Accelerate work on RAS-related drug candidates or risk losing first-mover advantage in precision oncology.
◆ Coverage
1 source · 21 Nov 2026
◆ Related on Wire
◆ Topics